SCHEMBL2199405

SCHEMBL2199405

COC(=O)c1ccc(C)c(C(=O)c2ccc(Nc3ccc(F)cc3Cl)cc2Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 11/20 0.61
MAPK13 O15264 10/20 0.61
MAPK12 P53778 10/20 0.61
MAPK11 Q15759 10/20 0.61
BCL6 P41182 1/20 0.48
BCOR Q6W2J9 1/20 0.48
MAPT P10636 2/20 0.42
AVPR2 P30518 1/20 0.42
OXTR P30559 1/20 0.42
AVPR1A P37288 1/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CSNK2A1 P68400 1/20 0.41
MEN1 O00255 1/20 0.41
CASP3 P42574 1/20 0.41
KMT2A Q03164 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
CNR2 P34972 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2199428 0.93 MAPK14 (0.60) MAPK14MAPK13MAPK12MAPK11BCL6
SCHEMBL2199211 0.89 MAPK13 (0.63) MAPK14MAPK13MAPK12MAPK11BCL6
SCHEMBL2198601 0.89 MAPK13 (0.63) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2200820 0.89 MAPK13 (0.55) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2199858 0.87 MAPK14 (0.52) MAPK14MAPK13MAPK12MAPK11BCL6
SCHEMBL2199501 0.86 MAPK13 (0.55) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2198797 0.86 MAPK14 (0.62) MAPK14MAPK13MAPK12MAPK11BCL6
SCHEMBL2197464 0.86 MAPK13 (0.51) MAPK14MAPK13MAPK12MAPK11BCL6
SCHEMBL2851969 0.85 MAPK14 (0.65) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2201621 0.84 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11BCL6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK14 697/4885MAPK13 1063/4885MAPK12 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.